NCT05143710View on ClinicalTrials.gov

The Clinical and Prognostic Features of PRES

CompletedOBSERVATIONAL
Enrollment

354

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Posterior Reversible Encephalopathy SyndromePregnancy OutcomesPreeclampsiaEclampsia
Interventions
DIAGNOSTIC_TEST

PRES in PE or E

patients diagnosed with posterior reversible encephalopathy syndrome with preeclampsia or eclampsia

Trial Locations (1)

510150

Department of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Dunjin Chen

OTHER

NCT05143710 - The Clinical and Prognostic Features of PRES | Biotech Hunter | Biotech Hunter